IFIT3 and pancreatic neoplasm: By re-analysis of a large gene array dataset on human pancreatic cancer samples from van den Broeck et al. [24] a trend towards higher expression of IFIT3 in primary tumors of patients with poor outcome and in metastases was observed as compared to expression profiles in tumors of patients with fairly good survival.